MedTrace Logo

Effects of a Targeted Prevention Program on Change-of-Direction Biomechanics and Performance in Elite Female Soccer Players

NCT07523178 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2026-04-17

No results posted yet for this study

Summary

Anterior cruciate ligament (ACL) injuries are common in female soccer and frequently occur during change-of-direction (COD) movements without contact. Biomechanical deficits during these movements are considered important risk factors.

This study aims to evaluate the effects of a targeted injury-prevention program on biomechanical movement quality and performance during change-of-direction tasks in female soccer players.

Participants will perform a 90° cutting task during which biomechanical movement quality will be assessed using the Cutting Movement Assessment Score (CMAS), while performance will be evaluated using cutting time measured with photoelectric timing gates. Participants will also perform the 505 Agility Test to assess additional change-of-direction performance.

In addition, subjective perceptions of functional confidence and performance will be collected using Likert-scale questionnaires.

The study will assess whether a structured prevention program integrated into regular training can improve biomechanical movement patterns and change-of-direction performance.

Conditions

  • Anterior Cruciate Ligament Injury

Interventions

BEHAVIORAL

Targeted Injury Prevention Program

A structured injury prevention program integrated into regular soccer training sessions and performed twice per week for six weeks. The program includes exercises targeting neuromuscular control, lower-limb strength, trunk stability, balance, plyometric ability, and change-of-direction technique.

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Principal Investigators

  • Mathilde Devits, PT, PhD candidate · University of Liege

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-30
Primary Completion
2026-05-18
Completion
2026-05-18

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07523178 on ClinicalTrials.gov